BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 37113210)

  • 1. Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults.
    Iwamoto SJ; Defreyne J; Kaoutzanis C; Davies RD; Moreau KL; Rothman MS
    Ther Adv Endocrinol Metab; 2023; 14():20420188231166494. PubMed ID: 37113210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks.
    Sudhakar D; Huang Z; Zietkowski M; Powell N; Fisher AR
    Neurourol Urodyn; 2023 Jun; 42(5):903-920. PubMed ID: 36403287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers and Facilitators to Gender-affirming Hormone Therapy in the Veterans Health Administration.
    Wolfe HL; Boyer TL; Shipherd JC; Kauth MR; Jasuja GK; Blosnich JR
    Ann Behav Med; 2023 Nov; 57(12):1014-1023. PubMed ID: 37436725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of a transgender and gender-diverse patient population in Utah: Use of electronic health records to advance clinical and health equity research.
    Ho TF; Zenger B; Mark B; Hiatt L; Sullivan E; Steinberg BA; Lyons A; Spivak AM; Agarwal C; Adelman M; Hotaling J; Kiraly B; Talboys S
    PLoS One; 2024; 19(5):e0302895. PubMed ID: 38713697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations for Gender-Affirming Hormonal and Surgical Care Among Transgender and Gender Diverse Adolescents and Adults With Congenital Heart Disease.
    Harrison DJ; Prada F; Nokoff NJ; Iwamoto SJ; Pastor T; Jacobsen RM; Yeung E
    J Am Heart Assoc; 2024 Feb; 13(3):e031004. PubMed ID: 38293963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine Screening for Transgender and Gender Diverse Adults Taking Gender-Affirming Hormone Therapy: a Narrative Review.
    Iwamoto SJ; Grimstad F; Irwig MS; Rothman MS
    J Gen Intern Med; 2021 May; 36(5):1380-1389. PubMed ID: 33547576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgenetic alopecia incidence in transgender and gender diverse populations: A retrospective comparative cohort study.
    Gao JL; Sanz J; Tan N; King DS; Modest AM; Dommasch ED
    J Am Acad Dermatol; 2023 Sep; 89(3):504-510. PubMed ID: 36780950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mental Healthcare Utilization of Transgender Youth Before and After Affirming Treatment.
    Hisle-Gorman E; Schvey NA; Adirim TA; Rayne AK; Susi A; Roberts TA; Klein DA
    J Sex Med; 2021 Aug; 18(8):1444-1454. PubMed ID: 34247956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender-affirming pharmacotherapy and additional health considerations: A contemporary review.
    Mercer J; Bandy S; Tang H; Wenger B; Ryan L; Lee G; Lipscomb J
    J Am Pharm Assoc (2003); 2023; 63(6):1669-1676.e1. PubMed ID: 37619851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Often-Circuitous Path to Affirming Mental Health Care for Transgender and Gender-Diverse Adults.
    Holt NR; Hope DA; Mocarski R; Woodruff N
    Curr Psychiatry Rep; 2023 Mar; 25(3):105-111. PubMed ID: 36773177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.
    Coleman E; Radix AE; Bouman WP; Brown GR; de Vries ALC; Deutsch MB; Ettner R; Fraser L; Goodman M; Green J; Hancock AB; Johnson TW; Karasic DH; Knudson GA; Leibowitz SF; Meyer-Bahlburg HFL; Monstrey SJ; Motmans J; Nahata L; Nieder TO; Reisner SL; Richards C; Schechter LS; Tangpricha V; Tishelman AC; Van Trotsenburg MAA; Winter S; Ducheny K; Adams NJ; Adrián TM; Allen LR; Azul D; Bagga H; Başar K; Bathory DS; Belinky JJ; Berg DR; Berli JU; Bluebond-Langner RO; Bouman MB; Bowers ML; Brassard PJ; Byrne J; Capitán L; Cargill CJ; Carswell JM; Chang SC; Chelvakumar G; Corneil T; Dalke KB; De Cuypere G; de Vries E; Den Heijer M; Devor AH; Dhejne C; D'Marco A; Edmiston EK; Edwards-Leeper L; Ehrbar R; Ehrensaft D; Eisfeld J; Elaut E; Erickson-Schroth L; Feldman JL; Fisher AD; Garcia MM; Gijs L; Green SE; Hall BP; Hardy TLD; Irwig MS; Jacobs LA; Janssen AC; Johnson K; Klink DT; Kreukels BPC; Kuper LE; Kvach EJ; Malouf MA; Massey R; Mazur T; McLachlan C; Morrison SD; Mosser SW; Neira PM; Nygren U; Oates JM; Obedin-Maliver J; Pagkalos G; Patton J; Phanuphak N; Rachlin K; Reed T; Rider GN; Ristori J; Robbins-Cherry S; Roberts SA; Rodriguez-Wallberg KA; Rosenthal SM; Sabir K; Safer JD; Scheim AI; Seal LJ; Sehoole TJ; Spencer K; St Amand C; Steensma TD; Strang JF; Taylor GB; Tilleman K; T'Sjoen GG; Vala LN; Van Mello NM; Veale JF; Vencill JA; Vincent B; Wesp LM; West MA; Arcelus J
    Int J Transgend Health; 2022; 23(Suppl 1):S1-S259. PubMed ID: 36238954
    [No Abstract]   [Full Text] [Related]  

  • 12. Gynecologic Care of Transgender and Gender-Diverse People.
    Ferrando CA
    Obstet Gynecol; 2024 Feb; 143(2):243-255. PubMed ID: 37963404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuation of Gender-affirming Hormones Among Transgender Adolescents and Adults.
    Roberts CM; Klein DA; Adirim TA; Schvey NA; Hisle-Gorman E
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3937-e3943. PubMed ID: 35452119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Gender-Affirming Surgeries and Mental Health Outcomes.
    Almazan AN; Keuroghlian AS
    JAMA Surg; 2021 Jul; 156(7):611-618. PubMed ID: 33909023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender-Affirming Mental Health Care Access and Utilization Among Rural Transgender and Gender Diverse Adults in Five Northeastern U.S. States.
    Reisner SL; Benyishay M; Stott B; Vedilago V; Almazan A; Keuroghlian AS
    Transgend Health; 2022 Jun; 7(3):219-229. PubMed ID: 36643056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Readiness assessments for gender-affirming surgical treatments: A systematic scoping review of historical practices and changing ethical considerations.
    Amengual T; Kunstman K; Lloyd RB; Janssen A; Wescott AB
    Front Psychiatry; 2022; 13():1006024. PubMed ID: 36339880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer and gender-affirming hormone therapy for transgender and gender-diverse (TGD) individuals.
    Cathcart-Rake EJ; Ruddy KJ; Tevaarwerk AJ; Jatoi A
    Maturitas; 2024 Mar; 181():107913. PubMed ID: 38262089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased Anogenital Gonorrhea and Chlamydia in Transgender and Gender Diverse Primary Care Patients Receiving Gender-Affirming Hormone Therapy.
    Reisner SL; Deutsch MB; Mayer KH; Pletta DR; Campbell J; Potter J; Keuroghlian AS; Hughto JMW; Asquith A; Pardee DJ; Harris A; Quint M; Grasso C; Gonzalez A; Radix A
    J Gen Intern Med; 2024 May; 39(7):1164-1172. PubMed ID: 37989820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of Breast Imaging in Transgender and Gender-Diverse Patients: Gender-Affirming Care, Histopathologic Findings, Breast Cancer Risk, and Screening Recommendations.
    Chowdhury A; Saad Eddin A; Kim Hsieh S; Policeni FC
    J Breast Imaging; 2024 May; 6(3):238-245. PubMed ID: 38613363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of gender affirming hormone treatment in transgender individuals - a retrospective cohort study.
    Muir CA; Guttman-Jones M; Man EJ
    Endocrine; 2024 Feb; ():. PubMed ID: 38386168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.